Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.65 CAD | 0.00% | -2.14% | -32.03% |
Business Summary
Number of employees: 29
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Helliwell
FOU | Founder | - | 12-07-22 |
Bruce Cousins
DFI | Director of Finance/CFO | 63 | 21-05-02 |
Amanda Malone
COO | Chief Operating Officer | - | 12-07-31 |
Mark Kowalski
CTO | Chief Tech/Sci/R&D Officer | 69 | 23-05-17 |
Vik Peck
IRO | Public Communications Contact | - | - |
Adam Peeler
IRC | Investor Relations Contact | - | - |
Murray Webb
PRN | Corporate Officer/Principal | - | 17-03-31 |
Ash Bassett
PRN | Corporate Officer/Principal | - | - |
Paul Brennan
PRN | Corporate Officer/Principal | - | 19-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Geyer
BRD | Director/Board Member | 61 | 13-01-13 |
John Montalbano
FOU | Founder | 59 | 13-01-13 |
Richard Glickman
BRD | Director/Board Member | 65 | 21-03-08 |
Simon Pimstone
CHM | Chairman | 56 | 13-01-13 |
James Helliwell
FOU | Founder | - | 12-07-22 |
Michael Wilmink
BRD | Director/Board Member | - | 13-01-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 35,622,553 | 33,153,908 ( 93.07 %) | 0 | 93.07 % |
Company contact information
Eupraxia Pharmaceuticals, Inc.
2067 Cadboro Bay Road Suite 201
V8R 5G4, Victoria
+
http://www.eupraxiapharmaceuticals.comSector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.03% | 94.58M | |
+40.80% | 53.67B | |
-8.05% | 38.76B | |
+35.79% | 38.86B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- EPRX Stock
- Company Eupraxia Pharmaceuticals Inc.